Inducible CD40 expression mediates NFκB activation and cytokine secretion in human colonic fibroblasts

Gut

Volumn 52, Issue 10, 2003, Pages 1448-1456

  Gelbmann, C M ^a   Leeb, S N ^a   Vogl, D ^a   Maendel, M ^a   Herfarth, H ^a   Scholmerich J ^a   Falk, W ^a   Rogler, G ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN;

ADDITION REACTION; ARTICLE; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOSCOPIC BIOPSY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURFACE PROPERTY; T LYMPHOCYTE;

ADULT; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; COCULTURE TECHNIQUES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; CYTOKINES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTESTINAL MUCOSA; MIDDLE AGED; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0141534417     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.10.1448     Document Type: Article

References (54)

1. Hamilton JA, Piccoli DS, Cebon J, et al. Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts. II.Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte-CSF production. Blood 1992;79:1413-19.
2. Maas-Szabowski N, Fusenig NE. Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 1996;107:849-55.
3. Dongari-Bagtzoglou AI, Ebersole JL. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res 1996;31:90-8.
4. Zhang S, Howarth PH, Roche WR. Cytokine production by cell cultures from bronchial subepithelial myofibroblasts. J Pathol 1996;180:95-101.
5. Burnstine MA, Elner SG, Strieter RM, et al. Orbital fibroblast interleukin-6 gene expression and immunomodulation. Ophthal Plast Reconstr Surg 1999;15:306-11.
6. Sakurada S, Kato T, Okamoto T. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L- cysteine and aspirin. Int Immunol 1996;8:1483-93.
7. Meyer JE, Berner I, Teran LM, et al. RANTES production by cytokine-stimulated nasal fibroblasts: its inhibition by glucocorticoids. Int Arch Allergy Immunol 1998;117:60-7.
8. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998;22:382-9.
9. Rogler G, Gelbmann CM, Vogl D, et al. Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand J Gastroenterol 2001;36:389-98.
10. Elner VM, Burnstine MA, Kunkel SL, et al. Interleukin-8 and monocyte chemotactic protein-1 gene expression and protein production by human orbital fibroblasts. Ophthal Plast Reconstr Surg 1998;14:119-25.
11. Xing Z, Jordana M, Braciak T, et al. Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. Am J Respir Cell Mol Biol 1993;9:255-63.
12. Nakatsuka K, Tanaka Y, Hubscher S, et al. Rheumatoid synovial fibroblasts are stimulated by the cellular adhesion to T cells through lymphocyte function associated antigen- 1/intercellular adhesion molecule-1. J Rheumatol 1997;24:458-64.
13. Stamenkovic I, Clark EA, Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. Embo J 1989;8:1403-10.
14. Durie FH, Foy TM, Masters SR, et al. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994;15:406-11.
15. Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
16. Staut RD, Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996;17:487-92.
17. Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43.
18. Cella M, Scheidegger D, Palmer-Lehmann K, et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-52.
19. Pinchuk LM, Klaus SJ, Magaletti DM, et al. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol 1996;157:4363-70.
20. Bjorck P, Banchereau J, Flores-Romo L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int Immunol 1997;9:365-72.
21. Brouty-Boye D, Pottin-Clemenceau C, Doucet C, et al. Chemokines and CD40 expression in human fibroblasts. Eur J Immunol 2000;30:914-19.
22. Dongari-Bagtzoglou AI, Warren WD, Berton MT, et al. CD40 expression by gingival fibroblasts: correlation of phenotype with function. Int Immunol 1997;9:1233-41.
23. Cao HJ, Wang HS, Zhang Y, et al. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem 1998;273:29615-25.
24. Sempowski GD, Chess PR, Phipps RP. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J Immunol 1997;158:4670-7.
25. Sempowski GD, Rozenblit J, Smith TJ, et al. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol 1998;274:C707-14.
26. van Kooten C, Banchereou J. Functional role of CD40 and its ligand. Int Arch Allergy Immunol 1997;113:393-9.
27. Laman JD, De Boer M, Hart BA. CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis. Dev Immunol 1998;6:215-22.
28. Grewal IS, Flavell RA. The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 1996;153:85-106.
29. Fanslow WC, Srinivasan S, Paxton R, et al. Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 1994;6:267-78.
30. Wykes M, Poudrier J, Lindstedt R, et al. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells. Eur J Immunol 1998;28:548-59.
31. Bishop GA, Hostager BS. Molecular mechanisms of CD40 signaling. Arch Immunol Ther Exp 2001;49:129-37.
32. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2-17.
33. Werneburg BG, Zoog SJ, Dang TT, et al. Molecular characterization of CD40 signaling intermediates. J Biol Chem 2001;276:43334-42.
34. Hostager BS, Catlett IM, Bishop GA. Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J Biol Chem 2000;275:15392-8.
35. Hostager BS, Bishop GA. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J Immunol 1999;162:6307-11.
36. Pullen SS, Dang TT, Crute JJ, et al. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem 1999;274:14246-54.
37. Rothe M, Sarma V, Dixit VM, et al. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 1995;269:1424-7.
38. Nakano H, Sakon S, Koseki H, et al. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc Natl Acad Sci U S A 1999;96:9803-8.
39. Ahonen C, Manning E, Erickson LD, et al. The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol 2002;3:451-6.
40. Lomaga MA, Yeh WC, Sarosi I, et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999;13:1015-24.
41. Stuber E, Strober W, Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996;183:693-8.
42. Liu Z, Geboes K, Colpaert S, et al. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions. J Immunol 2000;164:6005-14.
43. De Jong YP, Comiskey M, Kalled SL, et al. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology 2000;119:715-23.
44. van Kooten C. Immune regulation by CD40-CD40-1 interactions-2; Y2K update. Front Biosci 2000;5:D880-693.
45. Doucet C, Giran-Michel J, Canonica GW, et al. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha. Eur J Immunol 2002;32:2437-49.
46. Lazaar AL, Amrani Y, Hsu J, et al. CD40-mediated signal transduction in human airway smooth muscle. J Immunol 1998;161:3120-7.
47. Liu Z, Colpaert S, D'Haens GR, et al. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 1999;163:4049-57.
48. Sawada-Hase N, Kiyohara T, Miyagawa J, et al. An increased number of CD40-high monocytes in patients with Crohn's disease. Am J Gastroenterol 2000;95:1516-23.
49. Vuckovic S, Florin TH, Khalil D, et al. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Am J Gastroenterol 2001;96:2946-56.
50. Polese L, Angriman I, Cecchetto A, et al. The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation. Eur J Gastroenterol Hepatol 2002;14:237-41.
51. Ludwiczek O, Kaser A, Tilg H. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases. Int J Colorectal Dis 2003;18:142-7.
52. Rogler G, Hausmann M, Vogl D, et al. Isolation and phenotypic characterization of colonic mocrophages. Clin Exp Immunol 1998;112:205-15.
53. Rogler G, Brand K, Vogl D, et al. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998;115:357-69.
54. Musso A, Condon TP, West GA, et al. Regulation of ICAM-1-mediated fibroblast-T cell reciprocal interaction: implications for modulation of gut inflammation. Gastroenterology 1999;117:546-56.